237 related articles for article (PubMed ID: 34972756)
1. Cytoreductive Nephrectomy After Combination of Nivolumab Plus Ipilimumab for Mucinous Tubular and Spindle Cell Carcinoma of the Kidney With Bone Metastases: A Case Report.
Furubayashi N; Taguchi K; Negishi T; Miura A; Sato Y; Miyoshi M; Nakamura M
In Vivo; 2022; 36(1):510-521. PubMed ID: 34972756
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.
Yoshino M; Ishihara H; Nemoto Y; Nakamura K; Nishimura K; Tachibana H; Fukuda H; Toki D; Yoshida K; Kobayashi H; Iizuka J; Shimmura H; Hashimoto Y; Tanabe K; Kondo T; Takagi T
Jpn J Clin Oncol; 2022 Oct; 52(10):1208-1214. PubMed ID: 35780441
[TBL] [Abstract][Full Text] [Related]
3. Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to nivolumab plus ipilimumab.
Fuchizawa H; Kijima T; Takada-Owada A; Nagashima Y; Okazaki A; Yokoyama M; Nishihara D; Ishida K; Kamai T
IJU Case Rep; 2021 Sep; 4(5):333-337. PubMed ID: 34497997
[TBL] [Abstract][Full Text] [Related]
4. [METASTATIC Mucinous Tubular and Spindle Cell Carcinoma Treated with Nivolumab Successfully : A Case Report].
Takahashi Y; Numakura K; Aoyama Y; Okada S; Saito T; Muto Y; Koizumi A; Nara T; Chiba S; Kanda S; Saito M; Narita S; Inoue T; Satoh S; Nanjo H; Habuchi T
Hinyokika Kiyo; 2019 Sep; 65(9):363-367. PubMed ID: 31697878
[TBL] [Abstract][Full Text] [Related]
5. Editorial Comment on "Impact of cytoreductive nephrectomy prior to combination therapy of ipilimumab plus nivolumab in metastatic renal cell carcinoma".
Teishima J
Int J Urol; 2023 Sep; 30(9):752-753. PubMed ID: 37218357
[No Abstract] [Full Text] [Related]
6. Impact of Cytoreductive Nephrectomy Following Nivolumab Plus Ipilimumab Therapy for Patients With Advanced Renal Cell Carcinoma.
Shirotake S; Miyama YU; Baba Y; Tajima H; Okada Y; Nakazawa K; Usami Y; Yasuda M; Igarashi D; Kaneko GO; Kanao K; Oyama M; Nishimoto K
Anticancer Res; 2022 May; 42(5):2727-2735. PubMed ID: 35489743
[TBL] [Abstract][Full Text] [Related]
7. The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature.
Studentova H; Rusarova N; Ondruskova A; Zemankova A; Student V; Skanderova D; Melichar B
Curr Oncol; 2022 Aug; 29(8):5475-5488. PubMed ID: 36005171
[TBL] [Abstract][Full Text] [Related]
8. [Renal mucinous tubular and spindle cell carcinoma combined with multiple bone metastasis: a case report and literature review].
Huang ZX; Zhang XP; Dong S; Liu SJ; Yang RL; Zhou YS; Ma WG
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):732-736. PubMed ID: 30122780
[TBL] [Abstract][Full Text] [Related]
9. [Two Cases of Metastatic and Recurrent Non-Clear Cell Renal Cell Carcinoma Re-Diagnosed as Renal Mucinous Tubular and Spindle Cell Carcinoma during Long-Term Follow-Up].
Kubota M; Yamasaki T; Teramoto Y; Ito K; Takada H; Magaribuchi T; Sawada A; Akamatsu S; Negoro H; Saito R; Kobayashi T; Terada N; Inoue T; Kamba T; Ogawa O
Hinyokika Kiyo; 2018 Mar; 64(3):111-115. PubMed ID: 29684960
[TBL] [Abstract][Full Text] [Related]
10. [Deep and Durable Response After Discontinuation of Nivolumab/Ipilimumab Combination Therapy for Metastatic Renal Cell Carcinoma : A Case Report].
Tsuruta M; Shibasaki N; Iguch R; Yamaguchi T; Ota H; Fuchigami Y; Magaribuchi T; Naito H; Terai A
Hinyokika Kiyo; 2020 Dec; 66(12):443-448. PubMed ID: 33435655
[TBL] [Abstract][Full Text] [Related]
11. Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: a case report.
Fuu T; Iijima K; Kusama Y; Otsuki T; Kato H
J Med Case Rep; 2022 May; 16(1):193. PubMed ID: 35581611
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and pathologic features of renal mucinous tubular and spindle cell carcinoma].
Song ZG; Liu AJ; Gao J; Song X; Wei LX
Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):440-3. PubMed ID: 22088368
[TBL] [Abstract][Full Text] [Related]
13. Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial.
Motzer RJ; Russo P; Grünwald V; Tomita Y; Zurawski B; Parikh O; Buti S; Barthélémy P; Goh JC; Ye D; Lingua A; Lattouf JB; Albigès L; George S; Shuch B; Sosman J; Staehler M; Vázquez Estévez S; Simsek B; Spiridigliozzi J; Chudnovsky A; Bex A
Target Oncol; 2023 Sep; 18(5):639-641. PubMed ID: 37659025
[TBL] [Abstract][Full Text] [Related]
14. Mucinous spindle and tubular renal cell cancer: A rare variant of renal cell cancer.
Bajpai M; Pooja S; Tyagi M; Pathre A
J Cancer Res Ther; 2022; 18(4):1168-1170. PubMed ID: 36149179
[TBL] [Abstract][Full Text] [Related]
15. [Renal Mucinous Tubular and Spindle Cell Carcinoma : A Case Report].
Hamada K; Joraku A; Ichioka D; Emura M; Shimazui T
Hinyokika Kiyo; 2021 Jun; 67(6):233-238. PubMed ID: 34265898
[TBL] [Abstract][Full Text] [Related]
16. [Mucinous tubular and spindle cell carcinoma of kidney: a clinicopathological study].
Song HJ; Ma J; Zhou HB; Ma HH; Shi QL; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):444-8. PubMed ID: 22088369
[TBL] [Abstract][Full Text] [Related]
17. [Mucinous Tubular and Spindle Cell Carcinoma in a Patient on Hemodialysis : A Case Report].
Sasaki Y; Shiozaki K; Nakanishi R; Izaki H; Kanda K; Ishikawa E; Kudo E; Nagashima Y
Hinyokika Kiyo; 2018 Sep; 64(9):365-368. PubMed ID: 30369227
[TBL] [Abstract][Full Text] [Related]
18. A Pathological Complete Response to the Combination of Ipilimumab and Nivolumab in a Patient with Metastatic Renal Cell Carcinoma.
Studentova H; Zemankova A; Spisarova M; Skanderova D; Tudos Z; Melichar B; Student V
Medicina (Kaunas); 2022 Feb; 58(3):. PubMed ID: 35334512
[No Abstract] [Full Text] [Related]
19. [DEFERRED NEPHRECTOMY IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA AFTER A NEAR-COMPLETE RESPONSE TO IMMUNOTHERAPY].
Purim O; Raz O; Eisner A; Baram N; Leonov Polak M; Rybo L
Harefuah; 2022 Dec; 161(12):763-768. PubMed ID: 36916116
[TBL] [Abstract][Full Text] [Related]
20. [Complete Remission of Metastatic Renal Cell Carcinoma with Invasion of the Duodenum and Pancreas after Treatment with Nivolumab Plus Ipilimumab Followed by Axitinib and Surgery : A Case Report].
Hagimoto H; Yamazaki T; Kashima S; Yoshino T; Goto T; Sano T; Sawada A; Akamatsu S; Kobayashi T; Nakano K; Yagi S; Matsuoka Y; Fujimoto M; Kitamura T; Ogawa O
Hinyokika Kiyo; 2021 May; 67(5):197-203. PubMed ID: 34126663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
